EU Industry Renews Call For Digital Regulatory Infrastructure

‘No Further Excuse To Delay’ Says Medicines For Europe

Medicines for Europe has renewed its call for a modern digital regulatory infrastructure in the wake of the COVID-19 pandemic to bolster communication and preparedness for future health crises, insisting that there is “no further excuse to delay.”

Digital App Computer
A modern digital regulatory infrastructure is urgently needed, Medicines for Europe insists • Source: Shutterstock

There is “no further excuse to delay a digital regulatory infrastructure for medicines after the COVID-19 pandemic,” Medicines for Europe has declared in an open message to European heads of state and governments, calling for action to create a better co-ordinated regulatory framework for pharmaceuticals that will enable the region to better respond to future health crises.

[Sidebar#GB150589]

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Regulation

More from Policy & Regulation

  • For Generics, A Victory Lap – And A Warning – On Drug Shortages

    Avoiding disaster at the beginning of the pandemic and offering a pro-active supply chain blueprint should position the generics industry well for an onshoring debate in Congress, but a look back at March 2020 is a reminder that even small policy shifts can have a big impact.

  • GB-Policy&Regulation-Free: Article with different widgets

    Emerging CRISPR innovations, shifting regulatory landscapes, and rising partnerships are accelerating a paradigm shift in biotech pipelines

  • Overseas API Manufacturing Identified As Key Vulnerability In US Supply Chain

    After US President Joe Biden launched a review of the country’s API supply chain, the task force has reported back with key vulnerabilities that contribute to drug shortages and supply risks during a global public health emergency. According to the report, the lack of geographic diversity and dependence on foreign nations and anti-competitive actions by foreign nations are key areas of concern.